News & Events

Apica Cardiovascular Receives $5M Investment for Heart Surgery System

Apica Cardiovascular co-founders James Greene, Vinod Thourani, Jorge Jimenez and Ajit Yoganathan (left to right) point to the location on a heart model where their heart surgery system attaches. (Georgia Tech Photo: Gary Meek)

A Georgia Tech and Emory University medical device startup that has developed a system to simplify and standardize the technique for opening and closing the beating heart during cardiac surgery has received a $5.1 million investment. Read More >>


Highlights from CICT - Year 1

  • Worked closely with physicians at Children’s Healthcare of Atlanta (CHOA), Children’s Hospital of Philadelphia, and Children’s Hospital of Boston to address pediatric cardiovascular research and surgical planning tools. 
  • Dr. Jarek Rossignac, Professor of Computer Science in the School of Interactive Computing at Georgia Tech  was instrumental in this effort. Featured in a TV segment discussing cardiovascular surgical planning for children. Dr. Ajit Yoganathan and his research team in the Cardiovascular Fluid Mechanics Laboratory created a virtual tool to give surgeons a new way to predict and improve the outcome for pediatric heart patients, before they ever get to the operating room.
  • CICT’s director placed  the United States in a lead position by chairing the committee on standards for minimally invasive heart valve therapies at an international standards meeting with representatives from 18 countries. . He is the Chair of Subcommittee Two, dealing with cardiovascular implants and extracorporeal systems under the International Standards Organization Technical Committee 150 on implants for surgery. 
  • In partnership with Imperial College of London , organized, co-chaired and co-sponsored the 4th Biennial Heart Valve Biology and Tissue Engineering Meeting in Hilton Head, South Carolina focused on recent advances in valve biology and the development of tissue engineered heart valve replacements.  The meeting was designed to reflect the diversity of challenges faced by biologists, bioengineers, material scientists, clinicians and regulators and the multidisciplinary approach that is required for successful tissue engineering of heart valves. It provided a forum for presentation and discussion of cutting edge technology and recent advances in this field.
  • Worked with The Global Center for Medical Innovation (GCMI), which in 2010, was awarded $2.6 million to build and equip a prototyping design and development facility that will accelerate the commercialization of next-generation medical devices and technology. The center will be located in midtown Atlanta.
  • In partnership with Children’s Hospital of Boston, CICT successfully completed its first year of activities within an FDA-sponsored Pediatric Cardiovascular Device Consortium focused on cardiovascular devices.

User login